Skip to main content

Table 5 Percentage (%) of AE grades at cycle 1 by treatment in B35 trial

From: Visualizing adverse events in clinical trials using correspondence analysis with R-package visae

AE class

Adherent

Non-adherent

Average

Anastrozole

Tamoxifen

Anastrozole

Tamoxifen

G2

38.22

40.69

49.66

52.23

45.20

G3

2.22

3.91

10.61

11.94

7.63

G4

0.188

0.279

0.903

3.279

1.162